• IPOs Review of Chinese Biomedical Companies in 2021 May 23, 2022
    In 2021, there are 89 Chinese biomedical companies (according to the classification of "Pharmaceutical and Biological" based on the industry division method of Shenyin & Wanguo Securities) completed IPOs in the Chinese mainland, Hong Kong Region of China,
PharmaSources Customer Service